UBS raised the firm’s price target on Procter & Gamble to $172 from $166 and keeps a Buy rating on the shares. Numbers are likely moving lower on cost pressures, but the firm remains encouraged by the improved delivery on the top line, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble price target raised to $150 from $142 at TD Cowen
- Procter & Gamble price target raised to $163 from $162 at Deutsche Bank
- Procter & Gamble price target lowered to $162 from $170 at Evercore ISI
- Procter & Gamble price target raised to $164 from $158 at Wells Fargo
- Procter & Gamble: Price Target Raised to $150 as Strong Quarter Offsets Medium-Term Cost and Pricing Risks, Rating Stays Hold